Skip to main content

Day: August 4, 2020

Trius Reactivates to the TSX Venture Exchange

FREDERICTON, New Brunswick, Aug. 04, 2020 (GLOBE NEWSWIRE) — Trius Investments Inc. (TSXV: TRU.H) (“Trius” or the “Company”) is pleased to announce that it has obtained final acceptance of the TSX Venture Exchange (“TSXV”) in respect of its application for reactivation and graduation to the TSXV from the NEX Board of the TSXV as a Tier 2 investment issuer (the “Reactivation”). Effective August 6, 2020, trading in the Company’s common shares will take place on the TSXV under the trading symbol “TRU”.The Company’s application for Reactivation was based on Trius re-attaining compliance with applicable TSXV listing requirements. The Reactivation does not constitute a “Reverse Takeover” or “Change of Business” for purposes of TSXV Policies.The Reactivation is intended to continue Trius’ momentum following recent positive corporate developments,...

Continue reading

New AMD Radeon™ Pro 5000 Series GPUs Bring Exceptional Graphics Performance to Updated 27-inch iMac

SANTA CLARA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) today announced availability of new AMD Radeon™ Pro 5000 series GPUs for the updated 27-inch iMac. The new GPUs power a wide variety of graphically intensive applications and workloads, unleashing creativity and productivity for consumer and professional users alike.The new AMD Radeon Pro 5000 series GPUs are built on industry-leading 7nm process technology and advanced AMD RDNA™ graphics architecture. They feature up to 40 compute units and up to 16GB of high-speed GDDR6 memory while delivering up to 7.6 teraflops of single precision (FP32) computational performance.“AMD Radeon Pro 5000 series GPUs bring new levels of performance and flexibility to the updated 27-inch iMac,” said Scott Herkelman, corporate vice president and general manager, Graphics Business...

Continue reading

Nicotine Replacement Therapy Market worth USD 3.54 billion by 2027; Increasing Cases of Smoking Cessation in North America to Stoke Exponential Demand

Pune, Aug. 04, 2020 (GLOBE NEWSWIRE) — The global nicotine replacement therapy market is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to increasing incidence of chronic disease such as lung cancer, strokes, and respiratory ailments. Additionally, introduction of innovative products by major companies will favor market growth. This information is published by Fortune Business Insights, in its latest report, titled, “Nicotine Replacement Therapy (NRT) Market Size, Share & COVID-19 Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further observes that the market was valued at USD 2.55 billion in 2019 and is projected to reach...

Continue reading

Rovio Entertainment Corporation: Repurchase of own shares on 4 August 2020

Further information:Rene Lindell, CFO+358 207 888 300RovioIR@rovio.comDistribution:Nasdaq Helsinki LtdKey mediahttps://investors.rovio.com/enAbout Rovio:Rovio Entertainment Corporation is a global, games-first entertainment company that creates, develops and publishes mobile games, which have been downloaded 4.5 billion times so far. Rovio is best known for the global Angry Birds brand, which started as a popular mobile game in 2009, and has since evolved from games to various entertainment and consumer products in brand licensing. Today, Rovio offers multiple mobile games, animations and has produced The Angry Birds Movie, which opened number one in theatres in 50 countries. Its sequel, The Angry Birds Movie 2, released worldwide in August 2019. Rovio is headquartered in Finland and the company’s shares are listed on the main list...

Continue reading

INGENICO GROUP : Informations relatives au nombre total de droits de vote et d’actions composant le capital au 31 juillet 2020

INGENICO GROUPSociété Anonyme au capital de 63 713 047 eurosSiège social : 28/32 boulevard de Grenelle75015 ParisRCS Paris : 317 218 758Paris, le 4 août 2020Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement Général de l’Autorité des marchés financiersY compris les actions auto-détenuesDéduction faite des actions auto-détenues__________________Paris, 4th August 2020Statement about the number of shares and voting rights in compliance with the article L.233-8-II of the French Commercial code and the article 223-16 of the Financial Markets Authority (AMF – Autorité des marchés financiers)Pièce jointeDéclaration ddv 310720

Continue reading

Issuance by Safe Orthopaedics of new ordinary shares as compensation for the contribution of shares of the company LCI Medical

Final acquisition of 100% of the shares of LCI medical validated by the General Meeting held todayEragny-sur-Oise, France, August 4th, 2020, 18h00 CEST – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, presents today the terms and conditions of the acquisition of the company LCI Medical.On May 6th, 2020, Safe Orthopaedics announced it had entered into exclusive negotiations for the acquisition of the company LCI Medical, manufacturer of medical devices and historical and strategical supplier of Sage Orthopaedics. The acquisition of the totality of the securities of LCI Medical required payment in cash and in Safe Orthopaedics’ shares.The Board of Director of Safe Orthopaedics...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.